The Australian Technical Advisory Group on Immunisation (ATAGI) has made recommendations for use of Pfizer COVID-19 vaccine as a booster dose in adolescents aged 16-17 years.

See full statement here: https://www.health.gov.au/news/atagi-recommendations-for-use-of-pfizer-covid-19-vaccine-as-a-booster-dose-in-adolescents-aged-16-17-years

Eastbrooke patients concerned about their specific health circumstances should consult their GP.